-+ 0.00%
-+ 0.00%
-+ 0.00%

JASCAYD™ RECEIVES HEALTH CANADA AUTHORIZATION FOR A NEW, WELL-TOLERATED ORAL TREATMENT FOR ADULTS WITH IPF AND PPF

Reuters·10/13/2026 12:08:18